Loading term…
A standardized grading scale (1-5) developed by NCI to describe the severity of adverse events, commonly used in oncology clinical trials.
Neutropenia is graded: Grade 1 (ANC <LLN-1500), Grade 2 (1000-1500), Grade 3 (500-1000), Grade 4 (<500), Grade 5 (death from neutropenia complications).
NCI CTCAE v5.0
Applying CTCAE grades outside the clinical trial context where they were designed, or using outdated versions.
How do you handle severity grading when CTCAE criteria don't exactly fit a reported event?